Khurram Jamil
Equibles does not estimate personal net worth.
Get an email with a short summary when Galectin Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get GALT alertsAbout Khurram Jamil
Galectin Therapeutics Inc reported in an 8-K filed August 1, 2024 that Khurram Jamil was appointed Chief Medical Officer, effective August 1, 2024. The proxy statement of Galectin Therapeutics Inc reports total compensation of $1,052,128 for Khurram Jamil in fiscal 2025, including a base salary of $500,000. Disclosed compensation is on record for 2 fiscal years. Galectin Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Galectin Therapeutics Inc includes Joel Lewis (CEO and Board Member), Jack W. Callicutt (CFO), Benjamin S. Carson (Board Member) and 7 others.
“On August 1, 2024, Galectin Therapeutics Inc. (the "Company") announced the promotion of Dr. Khurram Jamil to Chief Medical Officer effective immediately.”
Affiliation history
-
Galectin Therapeutics Inc (GALT)
Proxy statement
CurrentStart not stated–present
Last confirmed October 13, 2026
Company network
Leadership on record at Galectin Therapeutics Inc
- Joel Lewis CEO, Board Member
- Jack W. Callicutt CFO
- Benjamin S. Carson Board Member
- Dr. Henry Brem Board Member
- Elissa J. Schwartz Board Member
- Gilbert F. Amelio Board Member
- Gilbert S. Omenn Board Member
- Harold H. Shlevin Board Member
- Henry Brem Board Member
- Kary Eldred Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Galectin Therapeutics Inc (GALT) | M.D., Chief Medical Officer | $500,000 | $1,052,128 |
| 2024 | Galectin Therapeutics Inc (GALT) | M.D., Chief Medical Officer | $365,909 | $945,847 |